238 related articles for article (PubMed ID: 10190897)
1. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
2. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
[TBL] [Abstract][Full Text] [Related]
3. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
[TBL] [Abstract][Full Text] [Related]
4. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.
Delehanty LL; Payne JA; Farrow SN; Brown R; Champion BR
Immunology; 1997 Mar; 90(3):383-7. PubMed ID: 9155645
[TBL] [Abstract][Full Text] [Related]
7. Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.
Sugahara K; Hayashi T; Dateki N; Hirakata Y; Harasawa H; Tomonaga M; Yamada Y; Kamihira S
Int J Hematol; 2002 Jul; 76(1):50-4. PubMed ID: 12138895
[TBL] [Abstract][Full Text] [Related]
8. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
Beltinger C; Kurz E; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Blood; 1998 May; 91(10):3943-51. PubMed ID: 9573033
[TBL] [Abstract][Full Text] [Related]
9. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
Satou Y; Yasunaga J; Yoshida M; Matsuoka M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
11. OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.
Kunitomi A; Hori T; Maeda M; Uchiyama T
Int J Hematol; 2002 Oct; 76(3):260-6. PubMed ID: 12416737
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
Mishima K; Nariai Y; Yoshimura Y
Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
[TBL] [Abstract][Full Text] [Related]
13. Soluble Fas (APO-1/CD95) isoform in adult T-cell leukemia.
Kamihira S; Yamada Y
Leuk Lymphoma; 2001 Mar; 41(1-2):169-76. PubMed ID: 11342370
[TBL] [Abstract][Full Text] [Related]
14. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
15. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration.
Imura A; Hori T; Imada K; Kawamata S; Tanaka Y; Imamura S; Uchiyama T
Blood; 1997 Apr; 89(8):2951-8. PubMed ID: 9108415
[TBL] [Abstract][Full Text] [Related]
16. Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival.
Tawara M; Maeda T; Yamada Y; Harasawa H; Tsuruda K; Sugahara K; Moriuchi R; Tomonaga M; Kamihira S
Cancer Lett; 2003 Apr; 193(2):235-42. PubMed ID: 12706882
[TBL] [Abstract][Full Text] [Related]
17. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
18. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
20. A naturally occurring soluble isoform of murine Fas generated by alternative splicing.
Hughes DP; Crispe IN
J Exp Med; 1995 Nov; 182(5):1395-401. PubMed ID: 7595210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
